NaviFUS Corp. operates as a medical device company. It provides solutions for crossing the blood-brain barrier (BBB) for enhanced oncology drug delivery. The firm's NaviFUS System, is designed to utilize non-invasive ultrasound energy to enable transient and safe enhancement of BBB permeability to facilitate the transport of small or large molecular CNS drugs to target tumor tissue at high precision for better treatment outcomes. The company was founded by Hao-Li Liu in 2015 and is headquartered in Taipei, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company